US PRECISION Implementation Study

Study identifier:D2287L00028

ClinicalTrials.gov identifier:NCT04891978

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

Implementation of the US PRECISION AIRQ™, Asthma Checklist, and Educational Resources (PRECISION Program) into Clinical Practice Using Telehealth and In-Person Platforms

Medical condition

asthma

Phase

N/A

Healthy volunteers

No

Study drug

-

Sex

All

Actual enrollment

857

Study type

Interventional

Age

13 Years - 130 Years

Date

Study Start Date: 20 Apr 2021
Primary Completion Date: 30 Sept 2022
Study Completion Date: 30 Sept 2022

Study design

Allocation: N/A
Endpoint Classification: -
Intervention Model: Single Group Assignment
Masking: -
Primary Purpose: Health Services Research

Verification:

Verified 01 Nov 2022 by AstraZeneca

Sponsors

AstraZeneca

Collaborators

-

Inclusion and exclusion criteria